Loading content…
Dr. James Lockhart, MD, FACC
Cardiology · GLP-1 cardiovascular outcomes · Clinical Reviewer
LinkedIn profileAbout
Dr. Lockhart is a board-certified cardiologist (American Board of Internal Medicine, Cardiovascular Disease) and Fellow of the American College of Cardiology. Clinical focus is preventive cardiology, GLP-1 cardiovascular outcome trials (SUSTAIN-6, LEADER, REWIND, SELECT), and risk reduction in patients with obesity + diabetes. Reviews GLP1Zoom content on cardiovascular topics, drug interactions with anticoagulants, and risk-benefit decisions. Independent practice; consulting reviewer (flat-fee).
Specialties
- Cardiology
- Cardiovascular disease prevention
- GLP-1 cardiovascular outcomes
- Preventive cardiology
- Anticoagulation management
Practice
18+ years of clinical practice
Residency: Brigham and Women's Hospital — Internal Medicine Residency 2009; Cardiology Fellowship 2012
Education
- MDHarvard Medical School2006
- BA, Molecular BiologyPrinceton University2002
Board certifications
- American Board of Internal Medicine — Internal Medicine
- American Board of Internal Medicine — Cardiovascular Disease
- Fellow, American College of Cardiology (FACC)
Prior positions
Brigham and Women's Hospital Cardiology
Attending Cardiologist
2012-2018
Mass General Cardiovascular Prevention Center
Director, Preventive Cardiology
2018-2023
Content reviewed
Topics where Dr. James Lockhart provides specialty review for GLP1Zoom editorial content.
Dr. James Lockhart, MD, FACC is one of 5 specialists on the GLP1Zoom Medical Review Board. Reviewers are independently practicing clinicians compensated on a flat-fee basis for review time; they do not receive affiliate commissions or referral payments.